Fidanacogene elaparvovec for treating moderately severe to severe haemophilia B [ID4032]

  • In development
  • GID-TA11117
  • Expected publication date: TBC

Documents

Documents created during the development process.

Declaration of interests

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 4032